The relationship between body weight and drug costs: An Italian population-based study

Clinical Therapeutics

Volumn 28, Issue 9, 2006, Pages 1472-1481

  Esposti, Ezio Degli ^a   Sturani, Alessandra ^a   Valpiani, Giorgia ^b   Di Martino, Mirko ^b   Ziccardi, Francesco ^c   Rita Cassani, Anna ^c   Baraccani, Cristina ^a   Gentile, Marco ^a   Puglia, Maria Grazia ^a   Esposti, Luca Degli ^d  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b Economics and Outcomes Research   (Italy)

^c Local Health Unit   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

body mass index; obesity; pharmacologic treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; GASTROINTESTINAL AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTECTIVE AGENT; RESPIRATORY TRACT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DATA ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG CLASSIFICATION; DRUG COST; DRUG EXPOSURE; EVALUATION; FEMALE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; REIMBURSEMENT; SCREENING; STATISTICAL SIGNIFICANCE;

ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; DEPRESSION; DRUG COSTS; DYSLIPIDEMIAS; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; HYPOGLYCEMIC AGENTS; ITALY; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33750192469     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.09.016     Document Type: Article

References (31)

1. DHHS publication PHS 91-50212. Healthy People 2000. National Health Promotion and Disease Prevention Objectives (1991), Dept of Health and Human Services, Washington, DC
2. National Audit Office. Tackling Obesity in England. Report by the Comptroller and Auditor General. HC 220, Session 2000-2001, 15 February, 2001 (2001), Stationery Office, London, UK
3. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity (2001), US Dept of Health and Human Services, Rockville, Md
4. Harris T., Cook E.F., Garrison R., et al. Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA 259 (1998) 1520-1524
5. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894 (2000) 1-253
6. Calle E.E., Thun M.J., Petrelli J.M., et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105
7. Allison D.B., Fontaine K.R., Manson J.E., et al. Annual deaths attributable to obesity in the United States. JAMA 282 (1999) 1530-1538
8. ISTAT. Indagine statistica sulle condizioni di salute della popolazione e sul ricorso ai servizi sanitari-1983. Notiziario ISTAT 4 no 8 (1984)
9. ISTAT. Indagine statistica sulle condizioni di salute della popolazione e sul ricorso ai servizi sanitari-1999-2000 (2002), ISTAT, Rome, Italy
10. Editorial. Black N. Developing high quality clinical databases. BMJ 315 (1997) 381-382
11. Black N. High-quality clinical databases: Breaking down barriers. Lancet 353 (1999) 1205-1206
12. Singh R., and Mangat N.S. Elements ofSurveySampling (1996), Kluwer Academic Publishers, Dordrecht, Netherlands
13. Degli Esposti E., Berto P., Buda S., et al. The Pandora Project: Results ofthe pilot study. Am J Hypertens 12 (1999) 790-796
14. Obesity: Preventing and Managing the Global Epidemic (1998), World Health Organization, Geneva, Switzerland
15. L'uso dei farmaci in Italia. Rapporto nazionale anno 2004 (2005), OsMed, Rome, Italy
16. Degli Esposti L., Di Martino M., Saragoni S., et al. Pharmacoeconomics of anti hypertensive drug treatment: An analysis of how long patients remain on various anti hypertensive therapies. J Clin Hypertens (Greenwich) 6 (2004) 76-84
17. Informatore farmaceutico (2002), Edizioni OEMF, Rome, Italy
18. Lew E.A., and Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32 (1979) 563-576
19. Lee I.M., Manson J.E., Hennekens C.H., and Paffenbarger Jr. R.S. Body weight and mortality. A 27-year follow-up of middleaged men. JAMA 270 (1993) 2823-2828
20. Pi-Sunyer F.X. Medical hazards of obesity. Ann Intern Med 119 (1993) 655-660
21. Gorstein J., and Grosse R.N. The indirect costs of obesity to society. Pharmacoeconomics 5 Suppl 1 (1994) 58-61
22. Manson J.E., Willett W.C., Stampfer M.J., et al. Bodyweight and mortality among women. N Engl J Med 333 (1995) 677-685
23. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
24. Perry I.J. Healthy diet and lifestyle clustering and glucose intolerance. Proc Nutr Soc 61 (2002) 543-551
25. Yanovski J.A., and Yanovski S.Z. Recent advances in basic obesity research. JAMA 282 (1999) 1504-1506
26. York D.A. Peripheral and central mechanisms regulating food intake and macronutrient selection. Obes Surg 9 (1999) 471-479
27. [published correction appears in Int J Obes. 1986;10: 79]. Burton B.T., Foster W.R., Hirsch J., and Van Itallie T.B. Health implications of obesity: An NIH Consensus Develop ment Conference. Intj Obes 9 (1985) 155-170
28. Seidell J.C. Obesity in Europe: Scaling the epidemic. Int J Obes Relat Metab Disord 19 Suppl 3 (1995) S1-S4
29. Flegal K.M., Carroll M.D., Kuczmarski R.J., and Johnson C.L. Overweight and obesity in the United States: Preva lence and trends, 1960-1994. Int J Obes Relat Metab Disord 22 (1998) 39-47
30. Mokdad A.H., Serdula M.K., Dietz W.H., et al. The spread of the obesity epidemic in the United States 1991-1998. JAMA 282 (1999) 1519-1522
31. Barth N., Ziegler A., Himmelmann G.W., et al. Significant weight gains in a clinical sample of obese children and adolescents between 1985 and 1995. Int J Obes Relat Metab Disord 21 (1997) 122-126